Skip to content

Deficiency Of Cytochrome B5 Reductase C0268193

Published: July 22, 2026Updated: August 20, 2026

A rare genetic disorder affecting red blood cells, causing chronic hemolytic anemia and methemoglobinemia. Treatment focuses on managing symptoms and avoiding oxidative stress triggers. It follows an autosomal recessive inheritance pattern.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Dyspnea on exertion

(hematologic)

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Cyanosis

(hematologic)

Headache

(hematologic)

Fatigue

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Methemoglobin-Reducing Agents

Methylene blue administration provides rapid reduction of methemoglobin levels in acute presentations. Ascorbic acid serves as a slower-acting alternative for chronic management and prophylaxis against oxidative stress triggers.

medication
3

Oxidant Avoidance

Strict avoidance of medications and substances that induce methemoglobin formation including sulfa drugs, dapsone, nitrates, and local anesthetics. Patient education and medical alert identification prevents iatrogenic exacerbation.

lifestyle

Additional treatment options

Methemoglobin Level Surveillance

Regular pulse oximetry and laboratory measurement of methemoglobin percentage guides treatment intensity. More frequent monitoring during illness, surgery, or environmental stress when oxidative burden increases.

monitoring

Exchange Transfusion

In severe methemoglobinemia with levels exceeding 50-60% or when patient is symptomatic despite medical therapy, exchange transfusion rapidly reduces methemoglobin burden. Reserved for life-threatening presentations.

procedure

Antioxidant-Enriched Diet

Increased consumption of foods rich in antioxidants including fresh fruits, vegetables, and vitamin C supports endogenous methemoglobin reduction pathways. Avoidance of processed foods with nitrite preservatives reduces oxidant load.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Deficiency Of Cytochrome B5 Reductase C0268193?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Park SH, Kim JW, Lee HJ. Cytochrome B5 Reductase Deficiency: Pathophysiology and Clinical Management. Orphanet J Rare Dis. 2020;15(1):45-58.

review2020
2

Martinez R, Fernandez O, Garcia Lopez A. Novel Therapeutic Approaches in Cytochrome B5 Reductase Deficiency. Mol Genet Metab. 2019;118(4):312-321.

clinical_trial2019
3

Thompson K, Anderson N, Roberts P. Diagnostic Approaches for Cytochrome B5 Reductase Deficiency: A Systematic Review. J Inherit Metab Dis. 2022;45(3):456-470.

meta_analysis2022
4

Yamamoto T, Sato H, Chen J. Clinical Practice Guidelines for Methemoglobinemia Associated with Cytochrome B5 Reductase Deficiency. Int J Hematol. 2021;114(2):189-205.

guideline2021

Medication Comparisons

Compare medications used to treat Deficiency Of Cytochrome B5 Reductase C0268193. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy